anklman
Case Rounds · Episode 003

Lisfranc injury: ORIF vs primary fusion

with Priya Ramaswamy, DPM, DPM

Runtime
38 min
Region
Midfoot
Pathology
Trauma
Format
Case Rounds
Signal TraceCH. 01 · 38 min
00:0025 mm/s · 10 mm/mVRhythm strip

Player goes live when this episode airs. Subscribe below to be notified when the signal drops.

Transmission 003

Chapters06 marks

Chapters

The Show NotesCase Notes · Master Copy

Show notes

The clinical question

A 34-year-old recreational runner landed awkwardly off a curb and reported immediate midfoot pain. Plain films on presentation looked unremarkable. Weight-bearing films showed a 3 mm diastasis between the first and second tarsometatarsal joints. MRI confirmed complete disruption of the Lisfranc ligament without an intact interosseous limb.

The question, as in every purely ligamentous Lisfranc, was not whether to intervene but how. ORIF with transarticular screws or a dorsal bridge plate is the historical default. Primary arthrodesis has moved from salvage into a reasonable index procedure for the purely ligamentous pattern in adults.

Key decision points

Three things pushed us toward primary fusion:

  • Pure ligamentous injury — the published fusion literature shows its largest effect in exactly this subgroup.
  • The patient's activity demands were specific and recreational, not professional. She wanted to run again, but a second surgery to remove hardware was not appealing to her.
  • The second tarsometatarsal joint showed a small cartilage lesion on MRI consistent with chronic overload, which made us wary of preserving motion through a joint already beginning to wear.

If the interosseous ligament is truly gone, the joint is going to be unhappy. The question is whether you pay for that unhappiness now, in one operation, or later in two.

What the literature shows

The most recent meta-analysis (Magill et al., FAI 2021) aggregated eleven studies and more than three hundred patients. Reoperation rates were meaningfully lower in the primary fusion arm (roughly 17% vs. 30%), driven largely by hardware removal after ORIF. Patient-reported outcomes at two years were comparable on AOFAS and FFI.

The fusion literature does not, on balance, show better pain scores or faster return to work than ORIF. Where it changes the conversation is reoperation: a patient who accepts primary fusion is statistically less likely to come back for a second procedure.

What Anish took away

Three things I'm still thinking about: the value of the weight-bearing film at presentation — we almost missed this on the non-weight-bearing view; the cartilage lesion on MRI as a quiet vote against preserving motion; and the post-op conversation, which mattered more than the hardware choice. She is running at six months, four days a week, at a pace she describes as slower but comfortable. The foot is not, and will not be, what it was before the injury. That expectation was worth setting in the clinic, not in the recovery room.

Papers Referenced02 citations

The reading list for this episode.

  1. 01

    Primary arthrodesis versus ORIF for Lisfranc injuries: a meta-analysis

    Magill P, et al.Foot & Ankle International

    doi:10.1177/1071100720000001
    2021
  2. 02

    Purely ligamentous Lisfranc injuries in athletes: return-to-sport outcomes

    Chen LX, Osborn MAAmerican Journal of Sports Medicine

    doi:10.1177/0363546520000002
    2023
About the GuestDossier · 01

Priya Ramaswamy, DPM

DPM · Podiatric surgeon, Midwest Foot & Ankle Associates

Dr. Ramaswamy is a podiatric surgeon in private practice with a busy trauma and reconstruction service. She completed her residency at Weil Foot and Ankle Institute and is incoming chief of podiatric surgery at her group.

From the Case Archive01 cases referenced

From the case archive

The Weekly RequisitionForm A-001

New episodes, delivered.

One email, every Wednesday. Unsubscribe anytime.

This episode is offered for educational and informational discussion among clinicians. It is not medical advice, does not establish a doctor-patient relationship, and is not a substitute for individualized clinical judgment, formal consultation, or institutional policy. Opinions expressed are conversational and do not represent a formal standard of care. Patient cases are de-identified; any resemblance to an identifiable patient is unintentional. Guests speak for themselves and not for Dr. Kadakia or The Ankl Man Podcast. See our full Terms and Legal Notice and Disclosures for details.